BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 113 filers reported holding BIOSCRIP INC in Q2 2015. The put-call ratio across all filers is 22.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $502,000 | -64.0% | 483,140 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $1,396,000 | +95.0% | 483,140 | +72.1% | 0.00% | +100.0% |
| Q2 2016 | $716,000 | +26.5% | 280,671 | +6.2% | 0.00% | 0.0% |
| Q1 2016 | $566,000 | +22.8% | 264,338 | +0.4% | 0.00% | 0.0% |
| Q4 2015 | $461,000 | -5.7% | 263,214 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $489,000 | -49.5% | 261,732 | -1.8% | 0.00% | 0.0% |
| Q2 2015 | $968,000 | -3.5% | 266,553 | +17.8% | 0.00% | 0.0% |
| Q1 2015 | $1,003,000 | -36.3% | 226,349 | +0.5% | 0.00% | -50.0% |
| Q4 2014 | $1,574,000 | -0.6% | 225,168 | -1.8% | 0.00% | 0.0% |
| Q3 2014 | $1,584,000 | -15.0% | 229,295 | +2.6% | 0.00% | -33.3% |
| Q2 2014 | $1,864,000 | +40.2% | 223,523 | +17.3% | 0.00% | +50.0% |
| Q1 2014 | $1,330,000 | -4.4% | 190,508 | +1.3% | 0.00% | 0.0% |
| Q4 2013 | $1,391,000 | -18.7% | 188,037 | -3.4% | 0.00% | -33.3% |
| Q3 2013 | $1,710,000 | -45.2% | 194,727 | +2.9% | 0.00% | -50.0% |
| Q2 2013 | $3,123,000 | – | 189,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |